Pages that link to "Q48106927"
Jump to navigation
Jump to search
The following pages link to Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions (Q48106927):
Displaying 37 items.
- Preclinical models of antipsychotic drug action (Q26827502) (← links)
- Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior. (Q27011274) (← links)
- Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder (Q28241583) (← links)
- Metabotropic glutamate receptors as novel targets for anxiety and stress disorders (Q28303826) (← links)
- Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior. (Q30381682) (← links)
- Comparison of the activation of somatostatin- and neuropeptide Y-containing neuronal populations of the rat amygdala following two different anxiogenic stressors (Q30447711) (← links)
- The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology (Q30453767) (← links)
- The role of glutamate in anxiety and related disorders (Q31029023) (← links)
- In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders (Q34612242) (← links)
- The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex (Q35623415) (← links)
- About a snail, a toad, and rodents: animal models for adaptation research (Q35971171) (← links)
- GABA and glutamate systems as therapeutic targets in depression and mood disorders (Q36066308) (← links)
- On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation (Q36828365) (← links)
- Functional internal complexity of amygdala: focus on gene activity mapping after behavioral training and drugs of abuse (Q36967668) (← links)
- The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety (Q37151763) (← links)
- Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1 (Q37169626) (← links)
- The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders (Q37172873) (← links)
- Inhibition of VTA neurons activates the centrally projecting Edinger-Westphal nucleus: evidence of a stress-reward link? (Q37365626) (← links)
- Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists (Q37775612) (← links)
- Does midbrain urocortin 1 matter? A 15-year journey from stress (mal)adaptation to energy metabolism (Q37857860) (← links)
- An allosteric modulator of metabotropic glutamate receptors (mGluR₂), (+)-TFMPIP, inhibits restraint stress-induced phasic glutamate release in rat prefrontal cortex (Q38565386) (← links)
- Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. (Q40458602) (← links)
- Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands (Q40498179) (← links)
- Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge (Q42500911) (← links)
- Midazolam inhibits neophobia-induced Fos expression in the rat hippocampus. (Q42676399) (← links)
- Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2/3 antagonism. (Q45390087) (← links)
- Stimulation of sensory neurons improves cognitive function by promoting the hippocampal production of insulin-like growth factor-I in mice. (Q45930961) (← links)
- Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTP (Q46463685) (← links)
- Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala. (Q46499848) (← links)
- Previous experience of ethanol withdrawal increases withdrawal-induced c-fos expression in limbic areas, but not withdrawal-induced anxiety and prevents withdrawal-induced elevations in plasma corticosterone (Q46937740) (← links)
- Behavioral Changes in Mice Lacking Interleukin-33. (Q47551953) (← links)
- Neuropeptide Y activates urocortin 1 neurons in the nonpreganglionic Edinger-Westphal nucleus (Q48344462) (← links)
- Difference in time course of modulation of synaptic transmission by group II versus group III metabotropic glutamate receptors in region CA1 of the hippocampus. (Q48397327) (← links)
- Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression (Q48935964) (← links)
- Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review (Q57476908) (← links)
- Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders (Q57513867) (← links)
- The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus (Q97556098) (← links)